CvC-SAD (Clinician vs Coach)Self-help Versions in a RCT
NCT ID: NCT05292612
Last Updated: 2023-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
110 participants
INTERVENTIONAL
2023-05-01
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Social Anxiety Disorder (SAD) is a common mental problem, where people experience severe and disabling anxiety about social situations and interactions. It is highly prevalent world-wide and in Hong Kong, causing significant suffering/distress. While evidence-based interventions exist, e.g., cognitive behavioural therapy (CBT), there will be not enough trained therapists to meet the treatment demand so that the majority of the SAD patients receive no treatment. Internet-based therapies may offer a solution, given that they deliver treatment more cost-efficiently by requiring lesser therapist time so that more patients can be treated with the same therapist resources. One UK internet-based CBT protocol for SAD, iCBT(C\&W), shows high efficacy and efficiency in initial UK and Hong Kong trials with Englishspeaking patients.
Objectives:
1. To develop and confirm the efficacy of a Chinese-language version of iCBT(C\&W), administered by clinical psychologists in standard therapist-guided format.
2. To develop an even more cost-efficient new self-help format with some minimal 'coaching' performed by trained psychology bachelor-level graduates - its efficacy expected as 'noninferior' to that of the therapist-guided format.
Overall design:
Three-arm parallel group randomised controlled noninferiority trial: Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD vs. Waitlist
Method:
The iCBT(C\&W) protocol will be translated into Chinese. Approximately 110 Chinese adults with SAD will be recruited in Hong Kong and randomised into one of two treatment conditions, therapist-guided versus self-help. The treatment lasts 14 weeks. The primary outcome measure will be Liebowitz Social Anxiety Scale (self-report version).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Guided and Unguided Online Self-help Psychological Intervention
NCT05160376
Virtual Reality Based Cognitive Behavioral Therapy for Social Anxiety Among Youths in Hong Kong
NCT06876779
Evaluating the Efficacy of Culturally Adapted iCT-SAD
NCT06562010
Online Cognitive Behavioral Intervention Program for Hong Kong People With Social Anxiety Disorder
NCT04995913
Cognitive Behavioural Couple Intervention Therapy for Chinese Couples With a Depressed Partner
NCT04590573
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard therapist-guided iCT-SAD vs. Waitlist
to examine if standard iCT-SAD delivered in Chinese is superior to waitlist.
participants in the experimental group would receive iCBT(C\&W) for SAD under the guidance of trained therapist.
iCBT(C&W) for SAD
iCBT(C\&W) for SAD implements all the key procedures of the face-to-face treatment. Patients are guided through the treatment by using secure messaging and regular telephone or webcam calls. The treatment comprises a series of online modules, each of which includes educational texts, patient testimonies, video illustrations, case examples, questionand- answer boxes, monitoring sheets, behavioural experiments and other homework assignments.
Guided self-help iCT-SAD vs. Waitlist
to examine if guided self-help iCT-SAD delivered in Chinese is superior to waitlist.
participants in the experimental group would receive iCBT(C\&W) for SAD under the guidance of trained coaches.
iCBT(C&W) for SAD
iCBT(C\&W) for SAD implements all the key procedures of the face-to-face treatment. Patients are guided through the treatment by using secure messaging and regular telephone or webcam calls. The treatment comprises a series of online modules, each of which includes educational texts, patient testimonies, video illustrations, case examples, questionand- answer boxes, monitoring sheets, behavioural experiments and other homework assignments.
Standard therapist-guided iCT-SAD vs. Guided self-help iCT-SAD
to examine if guided self-help iCT-SAD is noninferior to standard iCT-SAD.
participants would be randomised into two groups. one group of participants would receive iCBT(C\&W) for SAD under the guidance of trained therapist while the other group of participants would receive iCBT(C\&W) for SAD under the guidance of trained coaches.
iCBT(C&W) for SAD
iCBT(C\&W) for SAD implements all the key procedures of the face-to-face treatment. Patients are guided through the treatment by using secure messaging and regular telephone or webcam calls. The treatment comprises a series of online modules, each of which includes educational texts, patient testimonies, video illustrations, case examples, questionand- answer boxes, monitoring sheets, behavioural experiments and other homework assignments.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
iCBT(C&W) for SAD
iCBT(C\&W) for SAD implements all the key procedures of the face-to-face treatment. Patients are guided through the treatment by using secure messaging and regular telephone or webcam calls. The treatment comprises a series of online modules, each of which includes educational texts, patient testimonies, video illustrations, case examples, questionand- answer boxes, monitoring sheets, behavioural experiments and other homework assignments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Considers SAD their main problem
* Age 18 or over (no upper age limit)
* No current psychotropic mediation, or on a stable dose for at least two months without improvement, and willing to remain at this dose throughout trial
* Participant agrees not to start any other forms of treatment during the trial
* Chinese resident of Hong Kong
* Proficient in written traditional Chinese and spoken Cantonese
* Internet access from home
Exclusion
* current or past psychosis, bipolar disorder, or borderline personality disorder
* active suicidality
* 'Moderate' or 'Severe' Alcohol Use Disorder or Substance Use Disorder (based on DSM-5)
* No current or previous CBT for SAD (defined as at least 5 sessions, and including an exposure component), including internet-CBT studies
* Not another current emotional problem that is the participant's main concern (Participant must not be largely absorbed in another emotional problem, for which it would be unethical not to address as a priority)
18 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Patrick Wing-Leung LEUNG
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Patrick Leung, Prof.
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022.086-T
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.